SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-133878
Filing Date
2019-05-02
Accepted
2019-05-02 08:00:32
Documents
4
Period of Report
2019-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d743617d8k.htm 8-K 18487
2 EX-99.1 d743617dex991.htm EX-99.1 53532
3 GRAPHIC g743617d1.jpg GRAPHIC 7201
4 GRAPHIC g743617d2.jpg GRAPHIC 5163
  Complete submission text file 0001193125-19-133878.txt   90471
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37766 | Film No.: 19789788
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences